In patients with ocular hypertension or open angle glaucoma, lowering intraocular pressure reduces the risk of visual field loss

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1496, 2005-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brinzolamide/Timolol: In Open-Angle Glaucoma and Ocular Hypertension

By Croxtall Jamie D.   Scott Lesley J.  

Drugs & Aging, Vol. 26, Iss. 5, 2009-05 ,pp. : 437-446

Adis International

Access to resources Recommend Favorite

Estimated Comparative Costs of Achieving a 20% Reduction in Intraocular Pressure with Bimatoprost or Latanoprost in Patients with Glaucoma or Ocular Hypertension

By Fiscella Richard  

Drugs & Aging, Vol. 23, Iss. 1, 2006-01 ,pp. : 39-47

Adis International

Access to resources Recommend Favorite

A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension

By Eisenberg D.L.   Camras C.B.  

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 505-514

Adis International

Access to resources Recommend Favorite

Safety of Unoprostone Isopropyl as Mono- or Adjunctive Therapy in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

By Mello P.A.d.A.  

Drug Safety, Vol. 25, Iss. 8, 2002-01 ,pp. : 583-597

Adis International

Access to resources Recommend Favorite

Topical Bimatoprost: A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension

By Easthope S.E.   Perry C.M.  

Drugs & Aging, Vol. 19, Iss. 3, 2002-01 ,pp. : 231-248

Adis International

Access to resources Recommend Favorite